Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Papaemmanuil, Elli  [Clear All Filters]
2015
Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J, E Baxter J, Massie CE, Papaemmanuil E, Menon S, et al. Effect of Mutation Order on Myeloproliferative Neoplasms. N Engl J Med. 2015;372(7):601-612.
2016
Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med. 2016;374(23):2209-2221.
2021
Wedge E, Hansen JWerner, Dybedal I, Creignou M, Ejerblad E, Lorenz F, Werlenius O, Ungerstedt J, Holm MSkov, Nilsson L, et al. Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: Clinical and molecular genetic prognostic factors in a Nordic population. Transplant Cell Ther. 2021.
2022
Schnegg-Kaufmann ASarah, Thoms JAI, Bhuyan GSarower, Hampton H, Vaughan L, Rutherford KDiane, Kakadia PM, Lee HMei, Johansson EMv, Failes TW, et al. Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy. Blood. 2022.
Asimomitis G, Deslauriers AG, Kotini AG, Bernard E, Esposito D, Olszewska M, Spyrou N, Ossa JEsteban Ar, Mortera-Blanco T, Koche RPatrick, et al. Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs. Blood Adv. 2022.
2023
Franch-Expósito S, Mehine M, Ptashkin RN, Bolton KL, Bandlamudi C, Srinivasan P, Zhang L, Goodell MA, Gedvilaite E, Menghrajani K, et al. Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors. JCO Precis Oncol. 2023;7:e2300070.
Todisco G, Creignou M, Bernard E, Björklund A-C, Moura PLuis, Tesi B, Blanco TMortera, Sander B, Jansson M, Walldin G, et al. Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts. Clin Cancer Res. 2023.
Diamond BT, Ziccheddu B, Maclachlan KH, Taylor J, Boyle EMary, Ossa JEsteban Ar, Jahn TJacob, Affer M, Totiger TM, Coffey DG, et al. Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures. Blood. 2023.